Methenamine Hippurate

马尿酸乌洛托品

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameMethenamine Hippurate
Drug Alias Name六亚甲基四胺苯甲酰甘氨酸盐methenaminum环六亚甲基四胺 N-苯甲 酰甘氨酸盐metenamina马尿酸孟德立胺 +[10] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsLower Urinary Tract SymptomsPelvic Organ ProlapseUrinary Retention +[4] 
Global Approved IndicationsLower Urinary Tract Symptoms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires MajorelleQuagen Pharmaceuticals LlcTrihealth Inc +[4] 
Inactive CompaniesN/A
Active IndicationsLower Urinary Tract SymptomsPelvic Organ ProlapseUrinary Retention +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01XX05
Related LinksWikipediaDrugBankKEGG